MAPT and Alzheimer disease: Despite these functional insights into tau phenotypes and nucleocytoplasmic transport deficits, it remains to be established whether the karyopherin abnormalities observed in Alzheimer’s disease patient brain55–59,107 are a cause or a consequence of tau pathology.